Background: Little is known on the performance of the newly introduced health benefit assessment process, AMNOG, in Germany compared to other health technology assessment agencies.
Objective: ... Read more
Despite attempts to harmonize access to medicines for patients in Europe by numerous organizations including the European Commission, EUnetHTA, industry organizations, and patient groups, heterogeneity ... Read more
Health Technology Assessment (HTA) agencies in Europe provide recommendations on medicines and other health interventions based on systematic clinical and/or economic evaluations which are conducted ... Read more
According to the EUnetHTA definition1, health technology assessment (HTA) is a multidisciplinary process that summarises information about the medical, social, economic and ethical issues related ... Read more
Market-based pricing for pharmaceuticals remains the industry’s preferred solution to meeting the needs of patients and society’s demand for better medical treatment. Competitive markets are ... Read more